2 The Frontier Drug INT230-6 Has Shown Promising Therapeutic Results In Soft Tissue Sarcoma! Apr 16, 2025
3 Hutchison Pharmaceuticals Announces Approval Of Cd73 Monoclonal Antibody Mupadolimab In Phase I/Ib Clinical Trial In China Feb 22, 2025
6 New Targeted Drug For Leukaemia Approved, 35% Of Patients' Cancer Cells Disappear Completely! Feb 06, 2025
Read More Apparatus Canada has developed a hand-held detector to help reduce the use of antibiotics Apr 14, 2025
Read More Medical Neoadjuvant Chemotherapy Reduces Colon Cancer Recurrence Rate By 28%, With Fewer Post-Operative Complications, Study Shows Apr 03, 2025
Read More Apparatus World's First Antibody Targeting B7H7 Approved For Clinical Trial In The Us Apr 02, 2025
Read More Apparatus J. Enzyme Inhib. Med. Chem. | Protac Targeting Aimp2-Dx2: a New Therapy For Lung Cancer Apr 06, 2025
